Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Epinastine and Olopatadine for Contact Lens Wear Comfort
NCT00489398Phase 4Withdrawn
- Sponsor
- Milton M. Hom, OD, FAAO
- Start
- Jul 2007
- Modality
- Small Molecules
01
Overview
Phase 4 trial of epinastine and olopatadine in allergic conjunctivitis (AC) (2 arms), sponsored by Milton M. Hom, OD, FAAO. Primary endpoint: Contact lens objective and subjective clinical performance testing up to 3 months. Planned start Jul 2007; status: withdrawn.
02
Drugs
epinastineolopatadine
03
Conditions
allergic conjunctivitis (AC)
Beyond the preview
Go deeper on NCT00489398.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00489398.